期刊文献+

女性性功能障碍的药物治疗进展 被引量:6

Progress in Pharmacotherapy of Female Sexual Dysfunction
下载PDF
导出
摘要 近年来,女性性功能障碍的药物治疗研究取得较大发展,雌激素替代治疗能有效改善性交疼痛、性交困难,雄激素制剂有助于改善女性性欲低下,此外,5型磷酸二酯酶抑制剂、多巴胺受体兴奋剂、前列腺素E1、肾上腺素能受体阻滞剂、部分中药等多种药物及剂型治疗女性性功能障碍的研究结果令人鼓舞。现就女性性功能障碍的药物治疗方面的研究进展作一综述。 Recent years have seen great progress in the researches on the pharmacotherapy of female sexual dysfunction(FSD). Estrogen replacement therapy is effective on female sexual pain and dyspareunia; androgen can improve female hyposexuality; and a variety of drugs and medication forms are being studied for their efficacy on FSD, including the 5-phosphodiesterase inhibitor, dopamine receptor stimulant, prostaglandin El, adrenergic receptor blocker, some traditional Chinese medicine, and so on , which have yielded lots of inspiring findings .
作者 饶婷 张孝斌
出处 《中华男科学杂志》 CAS CSCD 2007年第11期1023-1027,共5页 National Journal of Andrology
关键词 性功能障碍 药物治疗 女性 sexual dysfunction pharmacotherapy female
  • 相关文献

参考文献27

  • 1Ponholzer A,Roehlich M,Racz U,et al.Female sexual dysfunction in a healthy Austrian cohorts:prevalence and risk factors[J].Eur Urol,2005,47(3):366-375.
  • 2Sidi H,Puteh SE,Abdul]ah N,et al.The Prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women[J].J Sex Med,2007,4 (2):311-321.
  • 3沈逆,王彩琴,张元芳.对235名上海市静安社区内女性性功能的现况调查[J].中国男科学杂志,2006,20(5):56-57. 被引量:2
  • 4Berman JR,Adhikari SP,Goldstein I.Anatomy and physiology of female sexual function and dysfunction:classification,evaluation and treatment options[J].Eur Urol,2000,38 (1):20-29.
  • 5Basson R,Leiblum SL,Brotto L,et al.Definitions of women's sexual dysfunction reconsidered:advocating expansion and revision[J].J Psychosom Obstet Gynaecol,2003,24(4):221-229.
  • 6González M,Viáara G,Caba F,et al.Sexual function,menopause and hormone replacement therapy(HRT)[J].Maturitas,2004,48(4):411-420.
  • 7Sipski ML,Alexander CJ,Rosen RC.Sexual response in women with spinal cord injuries:implications for our understanding of the able bodied[J].J Sex Marital Ther,1999,25(1):11-22.
  • 8Suckling J,Lethaby A,Kennedy R.Local oestrogen for vaginal atrophy in postmenopausal women[J].Cochrane Database Syst Rev,2006,18(4):CD001500.
  • 9Wang XN,Simmons HA,Salatto CT,et al.Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats[J].Menopause,2006,13(4):609-620.
  • 10Kim NN,Stankovic M,Armagan A,et al.Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat[J].BMC Womens Health,2006,6:14.

二级参考文献5

  • 1Basson R,Berman J,Burnett A,et al.Report of the International Consensus development conference on female sexual dysfunction:definitions and classifications.J Urol 2000; 163(3):888-893
  • 2Meston CM.Validation of the female sexual function idex (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder.J Sex Marital Ther 2003; 29(1):39-46
  • 3American Psychiatric Association.DSM-Ⅳ:Diagnostic and Statistical Manual of Mental Disorders,4th ed.Washington,D.C:American Psychiatric Press,1994:68
  • 4Basson R,Leiblum S,Brotto L,et al.Definitions of Women's sexual dysfunction reconsidered:advocating expansion and revision.J Psychosom Obstet Gynaecol 2003; 24(4):221-229
  • 5Byrd JE,Hyde JS,DeLamater JDet al.Sexuality during pregnancy and the year postpartum:J Fam Pract 1998; 33:143-151

共引文献1

同被引文献41

  • 1田贞姬,殷秀荣,辛钟成,高冰.中国中青年女性性功能调查[J].中国男科学杂志,2006,20(9):25-28. 被引量:9
  • 2曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2000,1.1224-1230.
  • 3Signorello LB, Harlow BL, Chekos AK, et al. Postpartum sexual functioning and its relationship to perineal trauma: A retrospective cohort study of primiparous women. Am J Obstet Gynecol, 2001, 184(5): 881-888.
  • 4Leiblum SR, Seehuus M. FSFI scores of women with persistent genital arousal disorder compared with published scores of women with female sexual arousal disorder and healthy controls. J Sex Med, 2009, 6(2) : 469-473.
  • 5Hatzimouratidis K, Hatzichristou D. Sexual dysfunctions: Classifications and definitions. J Sex Med, 2007, 4( 1 ) : 241-250.
  • 6Burri AV, Cherkas LM, Spector TD. The genetics and epidemiology of female sexual dysfunction : A review. J Sex Med, 2009,6(3) : 646-657.
  • 7Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI) : A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther, 2000, 26(2) : 191-208.
  • 8Song SH, Jeon H, Kim SW, et al. The prevalence and risk factors of female sexual dysfunction in young korean women : An intemet-based survey. J Sex Med, 2008, 5(7) : 1694-1701.
  • 9Asian E, Beji NK, Gungor I, et al. Prevalence and risk factors for low sexual function in women: A study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med, 2008, 5(9) : 2044-2052.
  • 10Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol, 2006, 175 ( 2 ) : 654- 658.

引证文献6

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部